Spartina

tirzepatide · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Spartina, covering 2025-12-16 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Tirzepatide (Spartina) in Obese Kidney Transplant Recipients [Phase 4]